Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Cash Flow: 2017-2024

Historic Net Cash Flow for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to -$72.6 million.

  • IDEAYA Biosciences' Net Cash Flow fell 15.17% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.5 million, marking a year-over-year decrease of 140.81%. This contributed to the annual value of -$72.6 million for FY2024, which is 181.53% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Net Cash Flow of -$72.6 million as of FY2024, which was down 181.53% from $89.0 million recorded in FY2023.
  • IDEAYA Biosciences' Net Cash Flow's 5-year high stood at $89.0 million during FY2023, with a 5-year trough of -$72.6 million in FY2024.
  • In the last 3 years, IDEAYA Biosciences' Net Cash Flow had a median value of -$23.4 million in 2022 and averaged -$2.3 million.
  • In the last 5 years, IDEAYA Biosciences' Net Cash Flow crashed by 217.02% in 2022 and then soared by 480.27% in 2023.
  • Over the past 5 years, IDEAYA Biosciences' Net Cash Flow (Yearly) stood at $38.0 million in 2020, then tumbled by 47.30% to $20.0 million in 2021, then slumped by 217.02% to -$23.4 million in 2022, then soared by 480.27% to $89.0 million in 2023, then crashed by 181.53% to -$72.6 million in 2024.